2019 annual financial data

Compass Therapeutics, Inc. 2019 Net margin

Compass Therapeutics, Inc. 2019 net margin with verified reported values.

Direct answer

Net margin was Not calculable.

Operating income was -34,052,000 USD and net income was -34,744,000 USD.
Operating cash flow was -31,741,000 USD.

Get free Compass Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-34,052,000 USD
Net income
-34,744,000 USD
Operating cash flow
-31,741,000 USD